Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The beta-2 adrenergic receptor (β₂AR), also known as ADRB2, is a member of the G protein-coupled receptor (GPCR) superfamily. It primarily binds the endogenous catecholamines epinephrine (adrenaline) and norepinephrine. Upon activation, β₂AR stimulates adenylate cyclase via Gs proteins, leading to increased intracellular cyclic AMP (cAMP), which mediates various physiological responses such as smooth muscle relaxation and bronchodilation.
Agonists bind to the receptor, activating Gs protein, increasing cAMP production, and activating protein kinase A (PKA), leading to downstream effects like smooth muscle relaxation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta adrenergic receptor beta2 subtype (BETA2).